Journal of Clinical Pharmacy and Therapeutics

Cover image for Vol. 37 Issue 5

October 2012

Volume 37, Issue 5

Pages 497–616

  1. Commentaries

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
  2. Review Articles

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
  3. Original Articles

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Palatability of crushed ß–blockers, converting enzyme inhibitors and thiazides (pages 544–546)

      L. Zgraggen, P. B. Faré, S. A. G. Lava, G. D. Simonetti, E. F. Fossali, C. Amoruso and M. G. Bianchetti

      Version of Record online: 4 APR 2012 | DOI: 10.1111/j.1365-2710.2011.01330.x

    2. Pharmacodynamic comparison of two formulations of Acarbose 100-mg tablets (pages 553–557)

      S. Lee, J. Y. Chung, K. S. Hong, S.-H. Yang, S.-Y. Byun, H.-S. Lim, S.-G. Shin, I.-J. Jang and K.-S. Yu

      Version of Record online: 19 MAR 2012 | DOI: 10.1111/j.1365-2710.2012.01339.x

  4. Pharmacokinetics

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
  5. Pharmacogenetics

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case–control study (pages 588–593)

      S.-W. Tang, X.-Z. Lv, Y. Zhang, S.-S. Wu, Z.-R. Yang, Y.-Y. Xia, D.-H. Tu, P.-Y. Deng, Y. Ma, D.-F. Chen and S.-Y. Zhan

      Version of Record online: 15 FEB 2012 | DOI: 10.1111/j.1365-2710.2012.01334.x

    2. Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients (pages 594–598)

      F. Z. Smires, C. Moreau, R. Habbal, V. Siguret, S. Fadili, J. L. Golmard, A. Assaidi, P. Beaune, M. A. Loriot and S. Nadifi

      Version of Record online: 8 APR 2012 | DOI: 10.1111/j.1365-2710.2012.01340.x

    3. Pharmacokinetics of tramadol in a diverse healthy Chinese population (pages 599–603)

      D.-Y. Xia, Y.-H. Wang, T. Guo, X. L. Li, X. Y. Su and L. S. Zhao

      Version of Record online: 20 MAR 2012 | DOI: 10.1111/j.1365-2710.2012.01345.x

  6. Case Reports

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Genetic predisposition to atorvastatin-induced myopathy: a case report (pages 604–606)

      M. Francesca Notarangelo, N. Marziliano, M. Antonietta Demola, F. Pigazzani, A. Guidorossi, P. Angelica Merlini and D. Ardissino

      Version of Record online: 14 MAY 2012 | DOI: 10.1111/j.1365-2710.2012.01337.x

    2. Lessons from two cases of anaphylaxis to proton pump inhibitors (pages 614–616)

      S.-W. Choi, J.-M. Han, Y.-J. Bae, Y. S. Lee, Y. S. Cho, H.-B. Moon and T.-B. Kim

      Version of Record online: 30 MAY 2012 | DOI: 10.1111/j.1365-2710.2012.01348.x

SEARCH

SEARCH BY CITATION